HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement of thermal stability of subtilisin J by changing the primary autolysis site.

Abstract
The thermostability of subtilisin J, an extracellular serine protease secreted from Bacillus stearothermophilus, has been improved by changing the primary autolysis site of the Asp-49 mutant protein. Previously we have shown that the Asp-49 mutant protein has proteolytic activity, but so unstable that it was primarily autolyzed in Tyr-58-Gln-59 peptide bond during cultivation (Jang et al. Biochim. Biophys. Acta. 1162, 233-235 1993). In the present study, to mitigate the autolytic degradation and increase the thermostability, we deleted the Tyr-58 residue using the Asp-49 mutant as a template. This mutant (Asp-49/delta Tyr-58 mutant) protein showed an improved resistance to heat treatment without changing the catalytic efficiency of the enzyme. These results show that change of primary autolysis site can stabilize the subtilisin.
AuthorsK H Bae, J S Jang, K S Park, S H Lee, S M Byun
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 207 Issue 1 Pg. 20-4 (Feb 06 1995) ISSN: 0006-291X [Print] United States
PMID7857265 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Recombinant Proteins
  • subtilisin J
  • Serine
  • Serine Endopeptidases
  • Subtilisins
Topics
  • Amino Acid Sequence
  • Autolysis
  • Enzyme Stability
  • Geobacillus stearothermophilus (enzymology)
  • Hot Temperature
  • Kinetics
  • Molecular Sequence Data
  • Mutagenesis, Site-Directed
  • Recombinant Proteins (biosynthesis, chemistry, metabolism)
  • Sequence Homology, Amino Acid
  • Serine
  • Serine Endopeptidases (chemistry)
  • Subtilisins (biosynthesis, chemistry, metabolism)
  • Thermodynamics

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: